From the publishers of JADPRO

Bone Protection Resource Center

Advertisement

Prognostic assessment of patients who receive radiotherapy for bone metastases from breast cancer

Last Updated: Friday, July 17, 2026

In a retrospective assessment of patients with breast cancer who received radiotherapy for bone metastases, researchers found that nuclear grade 3 status, brain/liver metastases, poor performance status, and previous systemic therapy were unfavorable prognostic factors.

Oncology Letters
Advertisement
Advertisement